🇺🇸 FDA
Patent

US 12049487

Universal chimeric antigen receptor T-cell preparation technique

granted A61KA61K2239/38A61K2239/48

Quick answer

US patent 12049487 (Universal chimeric antigen receptor T-cell preparation technique) held by GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD. expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD.
Grant date
Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2239/38, A61K2239/48, A61K40/11, A61K40/22